Potential Sickle Cell Disease Treatments on the Horizon
Brian Culley, CEO of Adventrx Pharmaceuticals Inc., is a busy man these days. Not only is his company readying itself for an important Phase III trial, but he also is in the midst of organizing the first Sickle Cell Disease Therapeutics Conference that will be held this week, Sept. 19, in New York City.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST